Fountain Valley, CA3 Active Studies

Essential Tremor Clinical Trials in Fountain Valley, CA

Find 3 actively recruiting essential tremor clinical trials in Fountain Valley, CA. Connect with local research sites and explore new treatment options.

3
Active Trials
3
Sponsors
2,250
Enrolling

Recruiting Essential Tremor Studies in Fountain Valley

About Essential Tremor Clinical Trials in Fountain Valley

Essential tremor is one of the most common movement disorders, causing involuntary shaking, most often in the hands. It is different from Parkinson's disease, though the two can be confused. Treatment includes medications, focused ultrasound, and deep brain stimulation for severe cases.

There are currently 3 essential tremor clinical trials recruiting participants in Fountain Valley, CA. These studies are seeking a combined 2,250 participants. Research is being sponsored by Sparrow Pharmaceuticals, Summit Therapeutics, vTv Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Essential Tremor Clinical Trials in Fountain Valley — FAQ

Are there essential tremor clinical trials in Fountain Valley?

Yes, there are 3 essential tremor clinical trials currently recruiting in Fountain Valley, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Fountain Valley?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Fountain Valley research site will contact you about next steps.

Are clinical trials in Fountain Valley free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Fountain Valley studies also compensate for your time and travel.

What essential tremor treatments are being tested?

The 3 active trials in Fountain Valley are testing new therapies including novel drugs, biologics, and treatment approaches for essential tremor.

Data updated July 13, 2026 from ClinicalTrials.gov